002688 金河生物
已收盘 10-23 15:00:00
资讯
新帖
简况
股市必读：金河生物新发布《关于金河生物科技股份有限公司2026年第五次临时股东会的法律意见书》
证券之星 · 10-12
股市必读：金河生物新发布《关于金河生物科技股份有限公司2026年第五次临时股东会的法律意见书》
金河生物（002688）披露部分股票期权注销完成公告，10月09日股价上涨1.73%
证券之星 · 10-09
金河生物（002688）披露部分股票期权注销完成公告，10月09日股价上涨1.73%
金河生物（002688）披露2024年股票期权激励计划第二个行权期行权结果暨股份上市公告，9月30日股价上涨1.17%
证券之星 · 09-30
金河生物（002688）披露2024年股票期权激励计划第二个行权期行权结果暨股份上市公告，9月30日股价上涨1.17%
股市必读：金河生物新发布《关于金河生物科技股份有限公司2026年第四次临时股东会的法律意见书》
证券之星 · 09-28
股市必读：金河生物新发布《关于金河生物科技股份有限公司2026年第四次临时股东会的法律意见书》
股市必读：金河生物新发布《关于金河生物科技股份有限公司2026年第四次临时股东会的法律意见书》
证券之星 · 09-24
股市必读：金河生物新发布《关于金河生物科技股份有限公司2026年第四次临时股东会的法律意见书》
金河生物（002688）披露回购注销部分限制性股票及注销库存股减少注册资本公告，9月23日股价下跌1.71%
证券之星 · 09-23
金河生物（002688）披露回购注销部分限制性股票及注销库存股减少注册资本公告，9月23日股价下跌1.71%
金河生物（002688）50万股限售股将于9月21日解禁，占总股本0.06%
证券之星 · 09-21
金河生物（002688）50万股限售股将于9月21日解禁，占总股本0.06%
金河生物（002688）495.6万股限售股将于9月15日解禁，占总股本0.59%
证券之星 · 09-15
金河生物（002688）495.6万股限售股将于9月15日解禁，占总股本0.59%
股市必读：金河生物新发布《关于2023年限制性股票激励计划首次授予第三个解除限售期解除限售股份上市流通的提示性公告》
证券之星 · 09-14
股市必读：金河生物新发布《关于2023年限制性股票激励计划首次授予第三个解除限售期解除限售股份上市流通的提示性公告》
金河生物（002688）披露2023年限制性股票激励计划首次授予第三个解除限售期解除限售股份上市流通提示性公告，9月10日股价下跌1.82%
证券之星 · 09-10
金河生物（002688）披露2023年限制性股票激励计划首次授予第三个解除限售期解除限售股份上市流通提示性公告，9月10日股价下跌1.82%
股市必读：金河生物（002688）9月4日董秘有最新回复
证券之星 · 09-07
股市必读：金河生物（002688）9月4日董秘有最新回复
金河生物：后续公司将通过强化全面预算管控、完善绩效考核、严控非必要开支
证券之星 · 09-01
金河生物：后续公司将通过强化全面预算管控、完善绩效考核、严控非必要开支
股市必读：金河生物新发布《第七届董事会第八次会议决议公告》
证券之星 · 09-01
股市必读：金河生物新发布《第七届董事会第八次会议决议公告》
金河生物（002688）披露美国子公司对外投资建设项目议案，8月31日股价下跌1.15%
证券之星 · 08-31
金河生物（002688）披露美国子公司对外投资建设项目议案，8月31日股价下跌1.15%
金河生物最新公告：美国子公司拟投建兽用添加剂及疫苗工厂项目
证券之星 · 08-31
金河生物最新公告：美国子公司拟投建兽用添加剂及疫苗工厂项目
金河生物（002688）2026年中报简析：增收不增利，公司应收账款体量较大
证券之星 · 08-29
金河生物（002688）2026年中报简析：增收不增利，公司应收账款体量较大
图解金河生物中报：第二季度单季净利润同比下降20.97%
证券之星 · 08-28
图解金河生物中报：第二季度单季净利润同比下降20.97%
金河生物（002688）披露2026年半年度报告全文及摘要，8月27日股价下跌0.57%
证券之星 · 08-27
金河生物（002688）披露2026年半年度报告全文及摘要，8月27日股价下跌0.57%
股市必读：金河生物（002688）8月14日董秘有最新回复
证券之星 · 08-17
股市必读：金河生物（002688）8月14日董秘有最新回复
金河生物：为保障园区污水处理能力的稳定，需要预留一定产能的安全边际
证券之星 · 08-14
金河生物：为保障园区污水处理能力的稳定，需要预留一定产能的安全边际
加载更多
公司概况
公司名称：
金河生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2012-07-13
主营业务：
金河生物科技股份有限公司的主营业务是动物保健品业务、环保业务及农产品加工业务。公司的主要产品是兽用化药、兽用疫苗、药物饲料添加剂、玉米淀粉及联产品、环保服务。公司是兽用化药金霉素预混剂行业的龙头企业，全球最大的兽用化药金霉素预混剂生产企业。
发行价格：
18.00
{"stockData":{"symbol":"002688","market":"SZ","secType":"STK","nameCN":"金河生物","latestPrice":4.87,"timestamp":1792738995000,"preClose":4.83,"halted":0,"volume":7764905,"delay":0,"changeRate":0.0083,"floatShares":749000000,"shares":836999999,"eps":0.0246,"marketStatus":"已收盘","change":0.04,"latestTime":"10-23 15:00:00","open":4.8,"high":4.87,"low":4.68,"amount":37038100,"amplitude":0.0393,"askPrice":4.87,"askSize":909,"bidPrice":4.86,"bidSize":128,"shortable":0,"etf":0,"ttmEps":0.0246,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792978200000},"marketStatusCode":5,"adr":0,"adjPreClose":4.83,"symbolType":"stock","openAndCloseTimeList":[[1792719000000,1792726200000],[1792731600000,1792738800000]],"highLimit":5.31,"lowLimit":4.35,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":837377701,"isCdr":false,"pbRate":1.78,"roa":"--","peRate":197.96748,"roe":"5.74%","epsLYR":0.0353,"committee":-0.266609,"marketValue":4078000000,"turnoverRate":0.0104,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-10-26。","floatMarketCap":3647000000},"requestUrl":"/m/hq/s/002688","defaultTab":"news","newsList":[{"id":"2674208846","title":"股市必读：金河生物新发布《关于金河生物科技股份有限公司2026年第五次临时股东会的法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674208846","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674208846?lang=zh_cn&edition=full","pubTime":"2026-10-12 04:10","pubTimestamp":1791749422,"startTime":"0","endTime":"0","summary":"公司公告汇总关于金河生物科技股份有限公司2026年第五次临时股东会的法律意见书北京市华联律师事务所出具法律意见书，认为金河生物2026年第五次临时股东会的召集召开程序、出席人员资格、召集人资格、表决程序及表决结果均符合相关法律法规及公司章程规定，会议决议合法有效；会议审议通过《关于增加公司2026年度日常经营关联交易预计额度的议案》，关联股东已回避表决，中小投资者单独计票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200001353.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674391868","title":"金河生物（002688）披露部分股票期权注销完成公告，10月09日股价上涨1.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674391868","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674391868?lang=zh_cn&edition=full","pubTime":"2026-10-09 22:46","pubTimestamp":1791557176,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘，金河生物报收于5.3元，较前一交易日上涨1.73%，最新总市值为44.38亿元。近日，金河生物科技股份有限公司披露《关于部分股票期权注销完成的公告》。2026年10月8日，该注销事项已由中国证券登记结算有限责任公司深圳分公司审核确认完成。本次注销符合相关规定，程序合规，不影响公司股本结构及财务状况，不损害公司及股东利益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900038752.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671075270","title":"金河生物（002688）披露2024年股票期权激励计划第二个行权期行权结果暨股份上市公告，9月30日股价上涨1.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671075270","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671075270?lang=zh_cn&edition=full","pubTime":"2026-09-30 17:43","pubTimestamp":1790761398,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘，金河生物报收于5.2元，较前一交易日上涨1.17%，最新总市值为43.54亿元。金河生物近日披露《关于2024年股票期权激励计划第二个行权期行权结果暨股份上市的公告》。本次行权新增股份数量为0股，行权股份上市日为2026年9月29日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000028512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670401443","title":"股市必读：金河生物新发布《关于金河生物科技股份有限公司2026年第四次临时股东会的法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2670401443","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670401443?lang=zh_cn&edition=full","pubTime":"2026-09-28 03:55","pubTimestamp":1790538912,"startTime":"0","endTime":"0","summary":"公司公告汇总：2026年第四次临时股东会审议通过回购注销限制性股票、注销回购专用账户库存股、变更注册资本及修订公司章程三项议案。公司公告汇总关于金河生物科技股份有限公司2026年第四次临时股东会的法律意见书北京市华联律师事务所就金河生物科技股份有限公司2026年第四次临时股东会的召集召开程序、出席人员资格、召集人资格、表决程序及表决结果等出具法律意见。上述事项完成后，公司总股本将由837,377,701股变更为836,082,701股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800001839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669337284","title":"股市必读：金河生物新发布《关于金河生物科技股份有限公司2026年第四次临时股东会的法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669337284","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669337284?lang=zh_cn&edition=full","pubTime":"2026-09-24 02:38","pubTimestamp":1790188692,"startTime":"0","endTime":"0","summary":"公司公告汇总：金河生物于2026年9月23日召开第四次临时股东会，审议通过回购注销限制性股票、注销回购专用账户库存股、变更注册资本及修订公司章程三项议案。公司公告汇总关于金河生物科技股份有限公司2026年第四次临时股东会的法律意见书北京市华联律师事务所就金河生物科技股份有限公司2026年第四次临时股东会的召集召开程序、出席人员资格、召集人资格、表决程序及表决结果等出具法律意见。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400002581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669484165","title":"金河生物（002688）披露回购注销部分限制性股票及注销库存股减少注册资本公告，9月23日股价下跌1.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669484165","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669484165?lang=zh_cn&edition=full","pubTime":"2026-09-23 22:28","pubTimestamp":1790173697,"startTime":"0","endTime":"0","summary":"截至2026年9月23日收盘，金河生物报收于5.17元，较前一交易日下跌1.71%，最新总市值为43.29亿元。该股当日开盘5.27元，最高5.27元，最低5.16元，成交额达3657.91万元，换手率为0.94%。公告显示，因2名激励对象离职、22名激励对象业绩考核不达标，公司拟回购注销限制性股票1,170,000股；同时拟将回购专用证券账户内125,000股库存股注销以减少注册资本。上述事项完成后，公司总股本将由837,377,701股变更为836,082,701股。公司债权人自公告之日起45日内可要求清偿债务或提供担保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300041208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669133349","title":"金河生物（002688）50万股限售股将于9月21日解禁，占总股本0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669133349","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669133349?lang=zh_cn&edition=full","pubTime":"2026-09-21 08:02","pubTimestamp":1789948936,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，金河生物于9月21日将有50.0万股限售股份解禁，为公司股权激励限售股份，占公司总股本0.06%。最近一年内，该股累计解禁495.6万股，占总股本的0.59%。本次解禁后，公司还有8616.61万股限售股份，占总股本10.29%。金河生物主营业务：专业从事动物保健品生产、销售、研发及服务,为客户提供一体化动物保健综合产品服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100000952.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667694543","title":"金河生物（002688）495.6万股限售股将于9月15日解禁，占总股本0.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667694543","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667694543?lang=zh_cn&edition=full","pubTime":"2026-09-15 08:14","pubTimestamp":1789431271,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，金河生物于9月15日将有495.6万股限售股份解禁，为公司股权激励限售股份，占公司总股本0.59%。本次解禁后，公司还有8538.06万股限售股份，占总股本10.2%。金河生物主营业务：专业从事动物保健品生产、销售、研发及服务,为客户提供一体化动物保健综合产品服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500005993.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667638618","title":"股市必读：金河生物新发布《关于2023年限制性股票激励计划首次授予第三个解除限售期解除限售股份上市流通的提示性公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667638618","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667638618?lang=zh_cn&edition=full","pubTime":"2026-09-14 03:23","pubTimestamp":1789327390,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，金河生物报收于5.24元，下跌2.78%，换手率1.78%，成交量13.33万手，成交额6988.03万元。公司公告汇总关于2023年限制性股票激励计划首次授予第三个解除限售期解除限售股份上市流通的提示性公告本次符合解除限售条件的激励对象为88名，可解除限售的限制性股票数量为4,956,000股，占公司总股本的0.5918%；限售起始日为2023年7月7日，限售期限36个月；上市流通日为2026年9月15日；公司层面及个人层面考核条件均已满足。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666591780","title":"金河生物（002688）披露2023年限制性股票激励计划首次授予第三个解除限售期解除限售股份上市流通提示性公告，9月10日股价下跌1.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666591780","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666591780?lang=zh_cn&edition=full","pubTime":"2026-09-10 22:30","pubTimestamp":1789050634,"startTime":"0","endTime":"0","summary":"近日，金河生物科技股份有限公司发布《关于2023年限制性股票激励计划首次授予第三个解除限售期解除限售股份上市流通的提示性公告》。公告显示，本次符合解除限售条件的激励对象为88名，可解除限售的限制性股票数量为4,956,000股，占公司总股本的0.5918%。限售起始日为2023年7月7日，限售期限36个月，上市流通日为2026年9月15日。公司层面及个人层面考核条件均已满足，相关股份将于解除限售后上市流通。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000042253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665627773","title":"股市必读：金河生物（002688）9月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2665627773","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665627773?lang=zh_cn&edition=full","pubTime":"2026-09-07 01:17","pubTimestamp":1788715028,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，金河生物报收于5.28元，上涨1.73%，换手率2.07%，成交量15.46万手，成交额8174.02万元。董秘最新回复投资者： 请问截止至2026年9月1日股东人数是多少谢谢董秘： 您好，为保证信息披露的公平性，公司会在定期报告中对股东情况作出统一披露。当日关注点交易信息汇总：9月4日主力资金净流入294.29万元，占总成交额3.6%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700000642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664790836","title":"金河生物：后续公司将通过强化全面预算管控、完善绩效考核、严控非必要开支","url":"https://stock-news.laohu8.com/highlight/detail?id=2664790836","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664790836?lang=zh_cn&edition=full","pubTime":"2026-09-01 15:03","pubTimestamp":1788246194,"startTime":"0","endTime":"0","summary":"金河生物回复：您好，公司2026年半年度管理费用较上年同期增加19.23%，主要系随着公司业务的发展，产品细分种类增加，从事相关工作的管理人员随之增加，叠加社保基数上调等因素总体职工薪酬同比增加幅度较大；受下游市场低迷影响，部分疫苗产能未能释放，停工产生的相关费用计入管理费用所致。后续公司将通过强化全面预算管控、完善绩效考核、严控非必要开支，统筹提升子公司运营效率，分类管控费用，推动费用增长逐步与收入水平相匹配。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100021215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000279","title":"股市必读：金河生物新发布《第七届董事会第八次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000279","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664000279?lang=zh_cn&edition=full","pubTime":"2026-09-01 03:07","pubTimestamp":1788203231,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，金河生物报收于5.16元，下跌1.15%，换手率1.08%，成交量8.07万手，成交额4166.83万元。公司公告汇总：董事会审议通过美国子公司两项对外投资项目，合计预计总投资约3,192.46万美元，资金来源为子公司自有或自筹资金，无需提交股东大会审议。交易信息汇总资金流向8月31日主力资金净流入139.13万元，占总成交额3.34%；游资资金净流入345.42万元，占总成交额8.29%；散户资金净流出484.55万元，占总成交额11.63%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100002636.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663001193","title":"金河生物（002688）披露美国子公司对外投资建设项目议案，8月31日股价下跌1.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663001193","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663001193?lang=zh_cn&edition=full","pubTime":"2026-08-31 22:31","pubTimestamp":1788186704,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，金河生物报收于5.16元，较前一交易日下跌1.15%，最新总市值为43.21亿元。该股当日开盘5.21元，最高5.22元，最低5.13元，成交额达4166.83万元，换手率为1.08%。近日，金河生物科技股份有限公司披露第七届董事会第八次会议决议公告。会议以9票同意、0票反对、0票弃权审议通过了《关于美国子公司对外投资建设项目的议案》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100037586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663070936","title":"金河生物最新公告：美国子公司拟投建兽用添加剂及疫苗工厂项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2663070936","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663070936?lang=zh_cn&edition=full","pubTime":"2026-08-31 19:29","pubTimestamp":1788175770,"startTime":"0","endTime":"0","summary":"金河生物(002688.SZ)公告称，公司董事会审议通过美国子公司对外投资建设项目议案，法玛威药业拟实施兽用添加剂工厂改扩建项目，预计总投资590.90万美元；法玛威生物拟实施兽用疫苗工厂新扩建项目，预计总投资2601.56万美元，合计约3192.46万美元。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100031248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","159646","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016197","title":"金河生物（002688）2026年中报简析：增收不增利，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016197","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663016197?lang=zh_cn&edition=full","pubTime":"2026-08-29 06:28","pubTimestamp":1787956132,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期金河生物发布2026年中报。截至本报告期末，公司营业总收入14.48亿元，同比上升4.13%，归母净利润1.31亿元，同比下降5.09%。本报告期金河生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达1999.94%。本次财报公布的各项数据指标表现一般。去年的净利率为-0.38%，算上全部成本后，公司产品或服务的附加值不高。本文数据来源于金河生物2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900011393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662570080","title":"图解金河生物中报：第二季度单季净利润同比下降20.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662570080","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662570080?lang=zh_cn&edition=full","pubTime":"2026-08-28 03:19","pubTimestamp":1787858364,"startTime":"0","endTime":"0","summary":"证券之星消息，金河生物2026年中报显示，上半年度公司主营收入14.48亿元，同比上升4.13%；归母净利润1.31亿元，同比下降5.09%；扣非净利润1.26亿元，同比下降1.85%；其中2026年第二季度，公司单季度主营收入7.06亿元，同比下降7.75%；单季度归母净利润6859.7万元，同比下降20.97%；单季度扣非净利润6578.98万元，同比下降16.96%；负债率56.1%，投资收益1.14万元，财务费用5029.63万元，毛利率37.78%。财报数据概要请见下图:本文数据来源于金河生物2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800006705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662086981","title":"金河生物（002688）披露2026年半年度报告全文及摘要，8月27日股价下跌0.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662086981","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662086981?lang=zh_cn&edition=full","pubTime":"2026-08-27 22:33","pubTimestamp":1787841218,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，金河生物报收于5.25元，较前一交易日下跌0.57%，最新总市值为43.96亿元。该股当日开盘5.29元，最高5.31元，最低5.21元，成交额达3453.82万元，换手率为0.88%。所有议案均获9票同意，0票反对，0票弃权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700056203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660170798","title":"股市必读：金河生物（002688）8月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2660170798","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660170798?lang=zh_cn&edition=full","pubTime":"2026-08-17 02:50","pubTimestamp":1786906220,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，金河生物报收于5.2元，下跌0.57%，换手率0.8%，成交量5.99万手，成交额3115.62万元。董秘最新回复投资者： 公司2025年污水处理业务的产能利用率是67.03%，还有1/3的产能可以使用，为什么还要投资建设新的项目？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700001046.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659112841","title":"金河生物：为保障园区污水处理能力的稳定，需要预留一定产能的安全边际","url":"https://stock-news.laohu8.com/highlight/detail?id=2659112841","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659112841?lang=zh_cn&edition=full","pubTime":"2026-08-14 16:57","pubTimestamp":1786697827,"startTime":"0","endTime":"0","summary":"证券之星消息，金河生物08月14日在投资者关系平台上答复投资者关心的问题。为保障园区污水处理能力的稳定，需要预留一定产能的安全边际，以便及时应对复杂成分污水的处理工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400027775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792867016396,"stockEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":-0.058},{"period":"3month","weight":0.0146},{"period":"6month","weight":-0.1467},{"period":"1year","weight":-0.2577},{"period":"ytd","weight":-0.1667}],"compareEarnings":[{"period":"1week","weight":-0.0069},{"period":"1month","weight":-0.0625},{"period":"3month","weight":-0.0324},{"period":"6month","weight":-0.0954},{"period":"1year","weight":-0.0591},{"period":"ytd","weight":-0.0701}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"金河生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"44466人(较上一季度减少7.34%)","perCapita":"16843股","listingDate":"2012-07-13","address":"内蒙古自治区呼和浩特市托克托县新坪路71号","registeredCapital":"83737万元","survey":" 金河生物科技股份有限公司的主营业务是动物保健品业务、环保业务及农产品加工业务。公司的主要产品是兽用化药、兽用疫苗、药物饲料添加剂、玉米淀粉及联产品、环保服务。公司是兽用化药金霉素预混剂行业的龙头企业，全球最大的兽用化药金霉素预混剂生产企业。","listedPrice":18},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金河生物(002688)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金河生物(002688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金河生物,002688,金河生物股票,金河生物股票老虎,金河生物股票老虎国际,金河生物行情,金河生物股票行情,金河生物股价,金河生物股市,金河生物股票价格,金河生物股票交易,金河生物股票购买,金河生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金河生物(002688)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金河生物(002688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}